KEPTIDE

Welcome to the Brand page for “KEPTIDE”, which is offered here for Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations for the prevention of sars-cov2 or covid-19; pharmaceutical preparations for the treatment and prevention of sars-cov2 or covid-19; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of sars-cov2 or covid-19; pharmaceutical preparations for sars-cov2 or covid-19; pharmaceutical preparations, elixirs for the treatment of sars-cov2 or covid-19; pharmaceutical products for treating respiratory diseases; pharmaceutical products for treating respiratory diseases and asthma; chemical preparations for pharmaceutical or medical purposes, for sars-cov2 or covid-19; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; therapeutic pharmaceutical for the treatment of sars-cov2 or covid-19;.

Its status is currently believed to be active. Its class is unavailable. “KEPTIDE” is believed to be currently owned by “Sotira, LLC”.

Owner:
SOTIRA, LLC
Owner Details
Description:
Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for the prevention of SARS-CoV2 or COVID-19; Pharmaceutical preparations for the treatment and prevention of SARS-CoV2 or COVID-19; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of SARS-CoV2 or COVID-19; Pharmaceutical preparations for SARS-CoV2 or COVID-19; Pharmaceutical preparations, elixirs for the treatment of SARS-CoV2 or COVID-19; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Chemical preparations for pharmaceutical or medical purposes, for SARS-CoV2 or COVID-19; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Therapeutic pharmaceutical for the treatment of SARS-CoV2 or COVID-19;
Categories: PHARMACEUTICAL PREPARATIONS SUBSTANCES